Emyria (ASX:EMD) Capex-to-Revenue : 0.01 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Emyria Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Emyria's Capital Expenditure for the six months ended in Dec. 2024 was A$-0.00 Mil. Its Revenue for the six months ended in Dec. 2024 was A$0.66 Mil.

Hence, Emyria's Capex-to-Revenue for the six months ended in Dec. 2024 was 0.01.

Emyria Capex-to-Revenue Historical Data

The historical data trend for Emyria's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emyria Capex-to-Revenue Chart

Emyria Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Capex-to-Revenue

Get a 7-Day Free Trial

0.20

0.55

1.50

2.03

0.56

Emyria Semi-Annual Data
	Jun19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Capex-to-Revenue	Get a 7-Day Free Trial						1.80	2.23	0.01	1.11	0.01

Competitive Comparison of Emyria's Capex-to-Revenue

For the Health Information Services subindustry, Emyria's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emyria's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Emyria's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Emyria's Capex-to-Revenue falls into.

Save Embed

;

Save Embed

;

Emyria Capex-to-Revenue Calculation

Emyria's Capex-to-Revenue for the fiscal year that ended in Jun. 2024 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-1.238)	/	2.203
	=	0.56

Emyria's Capex-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.003)	/	0.658
	=	0.00

Emyria (ASX:EMD) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Emyria Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Emyria's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Emyria Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Emyria Ltd (ASX:EMD) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

D2, 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007

Website

https://www.emyria.com

Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.